Acknowledgements

In response to Dr Vinod Scaria, Scientist, Institute of Genomics and Integrative Biology (IGIB) tweet, “One important point to consider regarding K417N (B.1.617.2 with the new K417N mutation) is evidence suggesting resistance to mAbs casirivimab and imdevimab”, in your article titled- ‘Is antibody cocktail offering the right mix?’, Roche would like to clarify that the casirivimab and imdevimab cocktail retained its neutralising activity against all COVID-19 variants tested. - Rajan S, Bengaluru

The article on 5G is very informative. You have raised very pertinent controversies that the lay public should be aware of. Congratulations for your effort. Thank you. - Dr Madhuchanda Kar, Kolkata

I would like to thank Bio Spectrum for engaging with Glenmark and covering detailed insights on our innovative brands Ryaltris and RyaltrisAZ as part of the interview, in their August 2021 edition. We look forward to continue our engagement with the BioSpectrum team in the future. - Alok Malik, Mumbai

The feature on Dassault Systemes in the cover story has turned out very well. Thank you - Dikshita Rajoria, New Delhi

Thank you for the coverage and filing stories on the Indian Institute of Technology (IIT). Much appreciated. We look forward to collaborating with you in the future as well. - Akhil Vaidya, New Delhi